NCT02095574View on ClinicalTrials.gov

A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

January 31, 2015

Conditions
Relapsed/Refractory Non-Hodgkin's Lymphoma
Interventions
DRUG

[14C]ABT-199 (GDC-0199)

\[14C\]ABT-199 will be administered as a single oral administration

Sponsors

Lead Sponsor

AbbVie

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

AbbVie

INDUSTRY